Cargando…

Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation

This cohort study investigates serum neurofilament light concentration as a biomarker associated with disability progression in multiple sclerosis in the absence of acute inflammation.

Detalles Bibliográficos
Autores principales:	Gafson, Arie R., Jiang, Xiaotong, Shen, Changyu, Kapoor, Raj, Zetterberg, Henrik, Fox, Robert J., Belachew, Shibeshih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826177/ https://www.ncbi.nlm.nih.gov/pubmed/35133438 http://dx.doi.org/10.1001/jamanetworkopen.2021.47588

Ejemplares similares

Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation
por: Jiang, Xiaotong, et al.
Publicado: (2023)

Serum neurofilament light as a biomarker in progressive multiple sclerosis
por: Kapoor, Raju, et al.
Publicado: (2020)

Slowly expanding lesions are a marker of progressive MS – No
por: Arnold, Douglas L, et al.
Publicado: (2021)

Neurofilaments in progressive multiple sclerosis: a systematic review
por: Williams, Thomas, et al.
Publicado: (2020)

Neurofilament light in blood – What more is needed for clinical implementation in multiple sclerosis?
por: Zetterberg, Henrik
Publicado: (2020)

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
por: Novakova, Lenka, et al.
Publicado: (2017)

Association of Serum Neurofilament Light Levels With Long-term Brain Atrophy in Patients With a First Multiple Sclerosis Episode
por: Plavina, Tatiana, et al.
Publicado: (2020)

Chronic lesion activity and disability progression in secondary progressive multiple sclerosis
por: Beynon, Vanessa, et al.
Publicado: (2022)

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
por: Disanto, Giulio, et al.
Publicado: (2017)

Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022)

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
por: Brune, Synne, et al.
Publicado: (2022)

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
por: Weston, Philip S. J., et al.
Publicado: (2019)

Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial
por: Williams, Thomas, et al.
Publicado: (2022)

No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab
por: Johnsson, Magnus, et al.
Publicado: (2022)

Association of serum neurofilament light with microglial activation in multiple sclerosis
por: Saraste, Maija, et al.
Publicado: (2023)

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression
por: Mollenhauer, Brit, et al.
Publicado: (2020)

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
por: Rojas, Julio C., et al.
Publicado: (2016)

Serum neurofilament light chain withstands delayed freezing and repeated thawing
por: Altmann, Patrick, et al.
Publicado: (2020)

Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
por: Sánchez-Valle, Raquel, et al.
Publicado: (2018)

No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion
por: Wallace, Colin, et al.
Publicado: (2018)

Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2022)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration
por: Weston, Philip S.J., et al.
Publicado: (2017)

Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis
por: Maggi, Pietro, et al.
Publicado: (2021)

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
por: Mattsson, Niklas, et al.
Publicado: (2017)

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
por: Shahim, Pashtun, et al.
Publicado: (2016)

Seven day pre-analytical stability of serum and plasma neurofilament light chain
por: Altmann, Patrick, et al.
Publicado: (2021)

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
por: Bergman, Joakim, et al.
Publicado: (2016)

Neurofilament light chain in the vitreous humor of the eye
por: Subramanian, Manju L., et al.
Publicado: (2020)

Heading in soccer increases serum neurofilament light protein and SCAT3 symptom metrics
por: Wallace, Colin, et al.
Publicado: (2018)

Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis
por: Elliott, Colm, et al.
Publicado: (2023)

Neurofilament light and tau as blood biomarkers for sports-related concussion
por: Shahim, Pashtun, et al.
Publicado: (2018)

Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas
por: Hepner, Adriana, et al.
Publicado: (2019)

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
por: Reinert, Marie-Christine, et al.
Publicado: (2020)

Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2019)

Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring
por: Calabresi, Peter A, et al.
Publicado: (2020)

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2023)

Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
por: Davies, Jennifer C, et al.
Publicado: (2023)

Serum Creatine, Not Neurofilament Light, Is Elevated in CHCHD10-Linked Spinal Muscular Atrophy
por: Järvilehto, Julius, et al.
Publicado: (2022)

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
por: Tyrberg, Tobias, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k5vq6ie5hfpjm0q8i01khu4835